addresses those concerns in a balanced, evidence-aware way
More patients receiving MOUNJARO 5 mg (3.0%), MOUNJARO 10 mg (5.4%), and MOUNJARO 15 mg (6.6%) discontinued treatment due to gastrointestinal adverse reactions than patients receiving placebo (0.4%)
HbA1c (for T2D users) Standard glycemic marker
Marketed under brand names such as Ozempic and Wegovy, semaglutide mimics the GLP-1 hormone, which helps regulate appetite and food intake
Inject the 2mL of air into the vialthis equalizes the pressure and makes it much easier to draw the liquid out
This behavioral change, rather than a direct drug effect, may contribute to inadequate consumption of B12-rich foods such as meat, fish, dairy products, and fortified cereals